Position in PBH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,566,391
-$104,786 QoQ
Shares Held
43,300
0.0% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OSSIAM holds $12,322,084 across 7 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
126,199 | $3,846,545 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
47,400 | $3,645,060 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
43,300 | $2,566,391 | |
| 4 | ZTS |
Zoetis Inc.
|
13,925 | $1,646,074 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
622 | $368,833 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,342 | $176,795 | |
| 7 | VTRS |
Viatris Inc
|
5,358 | $72,386 |
All Filings in PBH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,566,391 | 43,300 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,671,177 | 43,300 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,701,920 | 43,300 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||